section name header

Indications ⬇

High Alert


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: bradycardia, HF, hypotension

Endo: hypoglycemia

F and E: hyperkalemia

Local: infusion site reactions

Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS)

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

Route/Dosage ⬆ ⬇

US Brand Names ⬆ ⬇

Rapiblyk

Action ⬆ ⬇

  • Blocks stimulation of beta1(myocardial)-adrenergic receptors. Does not usually affect beta2(pulmonary, vascular, uterine)-adrenergic receptor sites.
Therapeutic effects:
  • Decreased ventricular rate (HR) in atrial fibrillation or atrial flutter.

Classifications ⬆ ⬇

Therapeutic Classification: antiarrhythmics

Pharmacologic Classification: beta blockers

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability.

Distribution: Well distributed to tissues.

Metabolism/Excretion: Primarily metabolized by pseudocholinesterases and carboxylesterases in the plasma to an active metabolite.

Half-Life: Primarily excreted in urine as metabolites (8% as unchanged drug).

Time/Action Profile ⬆ ⬇

(↓ HR)
ROUTEONSETPEAKDURATION
IVrapid10 minminutes



Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆

lan-DYE-oh-lol